XRAY

Dentsply Sirona Inc
NASDAQHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES

Key Statistics

Market Cap
$2.36B
P/E Ratio
EPS
$-3.04
Beta
0.89
52W High
$16.63
52W Low
$9.41
50-Day MA
$10.64
200-Day MA
$11.75
Dividend Yield
3.94%
Profit Margin
-17.10%
Forward P/E
8.26
PEG Ratio
0.75

About Dentsply Sirona Inc

Dentsply Sirona is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$3.68B
Gross Profit (TTM)$1.80B
EBITDA$556.00M
Operating Margin3.41%
Return on Equity-37.70%
Return on Assets2.26%
Revenue/Share (TTM)$18.44
Book Value$6.71
Price-to-Book1.77
Price-to-Sales (TTM)0.64
EV/Revenue1.216
EV/EBITDA91.48
Quarterly Earnings Growth (YoY)15.20%
Quarterly Revenue Growth (YoY)0.10%
Shares Outstanding$200.33M
Float$199.22M
% Insiders0.63%
% Institutions109.98%

Historical Volatility

HV 10-Day
51.31%
HV 20-Day
46.97%
HV 30-Day
44.30%
HV 60-Day
40.83%
HV Rank
59.9%

Volatility is currently expanding

Analyst Ratings

Consensus ($13.47 target)
2
Strong Buy
2
Buy
11
Hold
1
Sell
1
Strong Sell

Latest News

PDS Health Surpasses Five Million CEREC Chairside Restorations with Dentsply Sirona, Marking a Major Milestone in Scaled Digital Dentistry

This milestone reflects PDS Health's continued investment in digital technologies that help practices operate more efficiently, expand access to same-day restorative care and deliver a more consistent experience for patients. This milestone reflects PDS Health's continued investment in digital technologies that help practices operate more efficiently, expand access to same-day restorative care and deliver a more consistent experience for patients.

GlobeNewsWire7/1/2026Neutral
Dentsply Sirona Appoints John Fortson as Chief Financial Officer

Brings more than 25 years of experience leading transformation, capital deployment, and growth initiatives across global businesses Brings more than 25 years of experience leading transformation, capital deployment, and growth initiatives across global businesses

GlobeNewsWire6/11/2026Neutral
Dentsply Sirona to Participate in the 2026 Stifel Jaws & Paws Conference

CHARLOTTE, N.C., May 20, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 2026 Stifel Jaws & Paws Conference. Management is scheduled to present on Wednesday, May 27, 2026, at 3:35 p.m. ET.

GlobeNewsWire5/20/2026Neutral
Dentsply Sirona Reports First Quarter 2026 Results

News Summary Reported net sales of $880 million Delivered GAAP gross margin of 48.5% , GAAP net loss per share of ($0.05) Achieved adjusted gross margin of 50.7% , adjusted EBITDA margin of 14.7% , adjusted EPS of $0.27 Launched Smart View-Detect, the world's first FDA-cleared, AI-enabled diagnostic aid designed to identify teeth with periapical radiolucencies (PARL) in CBCT scans, now also CE-marked for use across Europe Continued to penetrate connected technology solutions market with new Atlanta Dental Supply distributor agreement Installed first CEREC ® system under the new Benco Dental distribution agreement, marking an important early milestone Began implementing new capital allocation strategy by reducing debt, managing liquidity, and improving working capital Reiterated 2026 outlook for net sales and adjusted EPS CHARLOTTE, N.C., May 05, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced its financial results for the first quarter of 2026.

GlobeNewsWire5/5/2026Neutral

More HEALTHCARE Stocks

Data last updated: 7/9/2026